Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer
Completed · Phase 1
Conditions studied: Pancreatic Cancer
In brief
The purpose of this study is to test a new treatment of pancreatic cancer that cannot be removed by surgery. This treatment is a Phase I dose escalation research study which will combine one drug at increasing doses with a fixed dose of a second drug and radiation therapy. The drug that will be used at increasing doses is gemcitabine whereas 5-fluorouracil will remain the same for all patients.
Key facts
- Study ID
- NCT00251355
- Run by
- Dana-Farber Cancer Institute
- People needed
- 40
- Starts
- 1998-01-01
- Expected to finish
- 2008-08-01
- Last updated by the study team
- 2016-12-20
Who can join
Age: 18 and older, up to 72. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Histologic confirmation of locally unresectable pancreatic adenocarcinoma. Patients with either measurable of evaluable disease are eligible.
- Unresectable, non-metastatic tumors. Unresectable patients include those with local extension of the tumor into adjacent structures and/or nodal metastasis.
- Total bilirubin < 2.0 mg/dl
- AST < 3x ULN
- Serum creatinine < 2.0 mg/dl
- WBC > 3,000/mm3
- Platelets > 100,000/mm3
- ECOG performance status < or = to 2
- Life expectancy of greater than 12 weeks
You may not qualify if…
- Evidence of peritoneal seeding by malignancy
- Prior radiation therapy or chemotherapy for pancreatic cancer
- Myocardial infarction in the past 6 months
- Major surgery in past two weeks
- Uncontrolled serious medical or psychiatric illness
- Pregnant or lactating women
- Concurrent malignancy of any site, except limited basal cell carcinoma or squamous cell carcinoma of the skin or carcinoma in situ of the cervix.
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.